Why the study?
A small animal model of chronic complete atrioventricular block reflecting clinical indices of bradycardia was needed to accelerate understanding of disease progression and therapeutic development.
Does focal somatic gene transfer of TBX18 create a biological pacemaker with a faster ventricular rate in a rat model of chronic complete atrioventricular block?
Does focal somatic gene transfer of TBX18 create a biological pacemaker with a faster ventricular rate in a rat model of chronic complete atrioventricular block?
A novel rat model of chronic complete AV block demonstrates that TBX18 gene transfer can successfully create a biological pacemaker with a faster ventricular rate than the intrinsic escape rhythm.
Should not yet inform clinical practice; leaves open TBX18 gene transfer as a biological pacemaker strategy in chronic AV block models.
Complete atrioventricular block (CAVB) is a life-threatening arrhythmia. A small animal model of chronic CAVB that properly reflects clinical indices of bradycardia would accelerate the understanding of disease progression and pathophysiology, and the development of therapeutic strategies. We sought to develop a surgical model of CAVB in adult rats, which could recapitulate structural remodeling and arrhythmogenicity expected in chronic CAVB. Upon right thoracotomy, we delivered electrosurgical energy subepicardially via a thin needle into the atrioventricular node (AVN) region of adult rats to create complete AV block. The chronic CAVB animals developed dilated and hypertrophied ventricles with preserved systolic functions due to compensatory hemodynamic remodeling. Ventricular tachyarrhythmias, which are difficult to induce in the healthy rodent heart, could be induced upon programmed electrical stimulation in chronic CAVB rats and worsened when combined with β-adrenergic stimulation. Focal somatic gene transfer of TBX18 to the left ventricular apex in the CAVB rats resulted in ectopic ventricular beats within days, achieving a de novo ventricular rate faster than the slow atrioventricular (AV) junctional escape rhythm observed in control CAVB animals. The model offers new opportunities to test therapeutic approaches to treat chronic and severe CAVB which have previously only been testable in large animal models.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2019) studied Complete atrioventricular block (CAVB). Focal somatic gene transfer of TBX18 (Adeno-TBX18) vs. Adeno-GFP was evaluated on Ventricular pacing rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: